Clinical trials
Enrolling by invitation Phase 2 trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
104 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2018 | 6 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 11 |
| 2024 | 13 |
| 2025 | 29 |
| 2026 | 24 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 104 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 9 |
| AbbVie | 3 |
| Sanofi | 3 |
| Adam Boxer | 2 |
| Akiva Mintz | 2 |
| Duke University | 2 |
| Massachusetts General Hospital | 2 |
| Michael Pulsipher | 2 |
| Northwestern University | 2 |
| QED Therapeutics, a BridgeBio company | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 6 |
| Dementia | 4 |
| Brain Injuries, Traumatic | 3 |
| Cognitive Dysfunction | 3 |
| Genetic Diseases, Inborn | 3 |
| Leukemia, Myeloid, Acute | 3 |
| Musculoskeletal Diseases | 3 |
| Obesity | 3 |
| Anxiety Disorders | 2 |
| Bone Diseases | 2 |
Trials
Showing 1 to 25 of 104. Each trial links to its page on Pharma Observatory.
4 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.